You just read:

Takeda Presents Real-World Vedolizumab Data in Ulcerative Colitis and Crohn's Disease at 2016 American College of Gastroenterology (ACG) Annual Scientific Meeting

News provided by

Takeda Pharmaceuticals U.S.A., Inc.

17 Oct, 2016, 08:27 ET